Cubist Systematic Strategies’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-8,261
Closed -$662K 2043
2016
Q4
$662K Sell
8,261
-8,105
-50% -$643K 0.05% 535
2016
Q3
$1.3M Buy
16,366
+8,142
+99% +$657K 0.08% 328
2016
Q2
$641K Sell
8,224
-33,804
-80% -$2.41M 0.04% 634
2016
Q1
$2.31M Buy
42,028
+39,279
+1,429% +$2.14M 0.13% 180
2015
Q4
$170K Sell
2,749
-20,144
-88% -$1.27M 0.01% 1407
2015
Q3
$1.44M Sell
22,893
-37
-0.2% -$2.64K 0.07% 392
2015
Q2
$1.68M Sell
22,930
-35,592
-61% -$2.57M 0.08% 336
2015
Q1
$3.83M Buy
58,522
+30,193
+107% +$2.01M 0.19% 115
2014
Q4
$1.84M Sell
28,329
-3,487
-11% -$225K 0.1% 276
2014
Q3
$1.91M Buy
31,816
+29,795
+1,474% +$1.95M 0.12% 227
2014
Q2
$140K Buy
+2,021
New +$131K 0.01% 1267

Other funds holding STJ

Cubist Systematic Strategies's STJ Position: Q1 2017 in Review

Cubist Systematic Strategies sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 8,261 shares — an estimated $662K sold.

Cubist Systematic Strategies first reported a position in STJ in Q2 2014 and held it in 11 quarters. The position peaked at $3.83M in Q1 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Cubist Systematic Strategies reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Cubist Systematic Strategies sold 8,261 St Jude Medical shares in Q1 2017, an estimated $662K.
  • Cubist Systematic Strategies first reported a position in St Jude Medical in Q2 2014 and held it in 11 quarters.
  • Cubist Systematic Strategies's St Jude Medical position peaked at $3.83M in Q1 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Cubist Systematic Strategies's 13F filing for Q1 2017, filed 15 May 2017.